2020 Q1 Form 10-Q Financial Statement
#000071439520000018 Filed on May 11, 2020
Income Statement
Concept | 2020 Q1 | 2019 Q4 | 2019 Q1 |
---|---|---|---|
Revenue | $43.57M | $47.34M | $41.19M |
YoY Change | 5.78% | 19.55% | 41.32% |
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | |||
YoY Change | |||
% of Gross Profit | |||
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | $2.300M | $2.200M | $2.000M |
YoY Change | 15.0% | 10.0% | 66.67% |
% of Gross Profit | |||
Operating Expenses | |||
YoY Change | |||
Operating Profit | |||
YoY Change | |||
Interest Expense | $7.315M | $7.598M | |
YoY Change | -3.72% | 114.94% | |
% of Operating Profit | |||
Other Income/Expense, Net | |||
YoY Change | |||
Pretax Income | $14.86M | $19.27M | $17.82M |
YoY Change | -16.59% | 49.38% | 24.61% |
Income Tax | $2.387M | $3.450M | $2.748M |
% Of Pretax Income | 16.06% | 17.9% | 15.43% |
Net Earnings | $12.47M | $15.82M | $15.07M |
YoY Change | -17.22% | 44.08% | 27.55% |
Net Earnings / Revenue | 28.62% | 33.42% | 36.58% |
Basic Earnings Per Share | $0.47 | $0.59 | $0.60 |
Diluted Earnings Per Share | $0.47 | $0.59 | $0.60 |
COMMON SHARES | |||
Basic Shares Outstanding | 26.66M shares | 26.66M shares | 24.97M shares |
Diluted Shares Outstanding | 26.66M shares | 24.97M shares |
Balance Sheet
Concept | 2020 Q1 | 2019 Q4 | 2019 Q1 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | |||
YoY Change | |||
Cash & Equivalents | $90.14M | $103.9M | $59.53M |
Short-Term Investments | |||
Other Short-Term Assets | |||
YoY Change | |||
Inventory | |||
Prepaid Expenses | |||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | |||
YoY Change | |||
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $96.38M | $96.65M | $89.60M |
YoY Change | 7.57% | 19.87% | 54.42% |
Goodwill | $121.3M | $121.3M | $103.8M |
YoY Change | 16.87% | 17.0% | 92.01% |
Intangibles | $11.66M | $12.66M | $9.121M |
YoY Change | 27.86% | 27.02% | 381.07% |
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | |||
YoY Change | |||
TOTAL ASSETS | |||
Total Short-Term Assets | |||
Total Long-Term Assets | |||
Total Assets | $4.324B | $4.398B | $3.896B |
YoY Change | 11.0% | 11.93% | 24.66% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $44.50M | $35.00M | $24.90M |
YoY Change | 78.71% | 63.55% | 28.35% |
Accrued Expenses | $9.300M | $9.100M | $8.800M |
YoY Change | 5.68% | ||
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $167.7M | $33.90M | |
YoY Change | -32.84% | ||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $53.80M | $44.10M | $33.70M |
YoY Change | 59.64% | 106.07% | 73.71% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $3.300M | $3.400M | $3.500M |
YoY Change | -5.71% | ||
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | $3.300M | $3.400M | $3.500M |
YoY Change | -5.71% | ||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $53.80M | $44.10M | $33.70M |
Total Long-Term Liabilities | $3.300M | $3.400M | $3.500M |
Total Liabilities | $3.740B | $3.824B | $3.416B |
YoY Change | 9.48% | 10.18% | 23.73% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | $253.8M | $253.1M | $222.2M |
YoY Change | 14.19% | 19.71% | 18.63% |
Common Stock | $301.4M | $305.6M | $254.6M |
YoY Change | 18.37% | 20.18% | 35.08% |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $583.5M | $573.8M | $479.2M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $4.324B | $4.398B | $3.896B |
YoY Change | 11.0% | 11.93% | 24.66% |
Cashflow Statement
Concept | 2020 Q1 | 2019 Q4 | 2019 Q1 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | $12.47M | $15.82M | $15.07M |
YoY Change | -17.22% | 44.08% | 27.55% |
Depreciation, Depletion And Amortization | $2.300M | $2.200M | $2.000M |
YoY Change | 15.0% | 10.0% | 66.67% |
Cash From Operating Activities | $23.94M | $19.40M | $15.34M |
YoY Change | 56.04% | -2.02% | 11.67% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $1.166M | -$3.800M | $1.629M |
YoY Change | -28.42% | 52.0% | -65.99% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $66.20M | -$28.20M | $19.70M |
YoY Change | 236.04% | -183.68% | -209.44% |
Cash From Investing Activities | $65.00M | -$31.90M | $18.03M |
YoY Change | 260.46% | -202.24% | -179.11% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | $5.065M | $4.245M | |
YoY Change | 19.32% | 23.4% | |
Common Stock Issuance & Retirement, Net | $4.495M | $0.00 | |
YoY Change | |||
Debt Paid & Issued, Net | $7.568M | $64.00K | |
YoY Change | 11725.0% | -99.86% | |
Cash From Financing Activities | -$102.7M | 27.20M | -$70.40M |
YoY Change | 45.86% | -235.32% | 233.71% |
NET CHANGE | |||
Cash From Operating Activities | $23.94M | 19.40M | $15.34M |
Cash From Investing Activities | $65.00M | -31.90M | $18.03M |
Cash From Financing Activities | -$102.7M | 27.20M | -$70.40M |
Net Change In Cash | -$13.74M | 14.70M | -$37.02M |
YoY Change | -62.88% | -52.43% | 22.8% |
FREE CASH FLOW | |||
Cash From Operating Activities | $23.94M | $19.40M | $15.34M |
Capital Expenditures | $1.166M | -$3.800M | $1.629M |
Free Cash Flow | $22.78M | $23.20M | $13.71M |
YoY Change | 66.07% | 4.04% | 53.25% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2020Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2020Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2019Q1 | us-gaap |
Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
|
0 | loan |
CY2019Q1 | us-gaap |
Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
|
0 | loan |
CY2019Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
0 | shares |
CY2020Q1 | dei |
Document Type
DocumentType
|
10-Q | |
CY2020Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Large Accelerated Filer | |
CY2020Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2020-03-31 | |
CY2020Q1 | dei |
Entity File Number
EntityFileNumber
|
001-15877 | |
CY2020Q1 | dei |
Entity Small Business
EntitySmallBusiness
|
false | |
CY2020Q1 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
47546 | |
CY2020Q1 | dei |
Entity Registrant Name
EntityRegistrantName
|
German American Bancorp, Inc. | |
CY2020Q1 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2020Q1 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
IN | |
CY2020Q1 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2020Q1 | dei |
Security12b Title
Security12bTitle
|
Common Stock, no par value | |
CY2020Q1 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
35-1547518 | |
CY2020Q1 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
711 Main Street | |
CY2020Q1 | dei |
Trading Symbol
TradingSymbol
|
GABC | |
CY2020Q1 | dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | |
CY2020Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2020Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2020 | |
CY2020Q1 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
CY2020Q1 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2020Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000714395 | |
CY2019Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
45000000 | shares |
CY2020Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
26500767 | shares |
CY2020Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
45000000 | shares |
CY2020Q1 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Jasper | |
CY2020Q1 | us-gaap |
Cash And Due From Banks
CashAndDueFromBanks
|
48293000 | USD |
CY2019Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
26671368 | shares |
CY2020Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
26498279 | shares |
CY2019Q4 | gabc |
Troubleddebtrestructuringadditionallendingamount
Troubleddebtrestructuringadditionallendingamount
|
0 | USD |
CY2019Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
0 | shares |
CY2019Q1 | us-gaap |
Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
|
0.17 | |
CY2020Q1 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2020Q1 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2020Q1 | us-gaap |
Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
|
0.19 | |
CY2019Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
1 | |
CY2020Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
1 | |
CY2020Q1 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
IN | |
CY2020Q1 | dei |
City Area Code
CityAreaCode
|
812 | |
CY2020Q1 | dei |
Local Phone Number
LocalPhoneNumber
|
482-1314 | |
CY2019Q4 | us-gaap |
Cash And Due From Banks
CashAndDueFromBanks
|
59971000 | USD |
CY2020Q1 | gabc |
Federal Funds Sold And Interest Bearing Deposits In Banks And Other Financial Institutions
FederalFundsSoldAndInterestBearingDepositsInBanksAndOtherFinancialInstitutions
|
41847000 | USD |
CY2019Q4 | gabc |
Federal Funds Sold And Interest Bearing Deposits In Banks And Other Financial Institutions
FederalFundsSoldAndInterestBearingDepositsInBanksAndOtherFinancialInstitutions
|
43913000 | USD |
CY2020Q1 | us-gaap |
Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
|
90140000 | USD |
CY2019Q4 | us-gaap |
Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
|
103884000 | USD |
CY2020Q1 | us-gaap |
Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
|
1985000 | USD |
CY2019Q4 | us-gaap |
Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
|
1985000 | USD |
CY2020Q1 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
875787000 | USD |
CY2019Q4 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
854825000 | USD |
CY2020Q1 | us-gaap |
Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
|
353000 | USD |
CY2019Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
96651000 | USD |
CY2020Q1 | us-gaap |
Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
|
625000 | USD |
CY2019Q4 | us-gaap |
Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
|
425000 | USD |
CY2020Q1 | us-gaap |
Notes Receivable Net
NotesReceivableNet
|
2977092000 | USD |
CY2019Q4 | us-gaap |
Notes Receivable Net
NotesReceivableNet
|
3060813000 | USD |
CY2020Q1 | us-gaap |
Federal Home Loan Bank Stock
FederalHomeLoanBankStock
|
13968000 | USD |
CY2019Q4 | us-gaap |
Federal Home Loan Bank Stock
FederalHomeLoanBankStock
|
13968000 | USD |
CY2020Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
96383000 | USD |
CY2019Q4 | us-gaap |
Interest Receivable And Other Assets
InterestReceivableAndOtherAssets
|
44210000 | USD |
CY2020Q1 | us-gaap |
Assets
Assets
|
4323853000 | USD |
CY2019Q4 | us-gaap |
Assets
Assets
|
4397672000 | USD |
CY2020Q1 | us-gaap |
Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
|
869847000 | USD |
CY2019Q4 | us-gaap |
Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
|
353000 | USD |
CY2020Q1 | us-gaap |
Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
|
15561000 | USD |
CY2019Q4 | us-gaap |
Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
|
17713000 | USD |
CY2020Q1 | us-gaap |
Financing Receivable Before Allowance For Credit Loss And Fee
FinancingReceivableBeforeAllowanceForCreditLossAndFee
|
3018416000 | USD |
CY2019Q4 | us-gaap |
Financing Receivable Before Allowance For Credit Loss And Fee
FinancingReceivableBeforeAllowanceForCreditLossAndFee
|
3081973000 | USD |
CY2020Q1 | us-gaap |
Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount
FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount
|
-4683000 | USD |
CY2019Q4 | us-gaap |
Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount
FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount
|
-4882000 | USD |
CY2020Q1 | us-gaap |
Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
|
36641000 | USD |
CY2019Q4 | us-gaap |
Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
|
16278000 | USD |
CY2020Q1 | us-gaap |
Goodwill
Goodwill
|
121306000 | USD |
CY2019Q4 | us-gaap |
Goodwill
Goodwill
|
121306000 | USD |
CY2020Q1 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
11662000 | USD |
CY2019Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
12656000 | USD |
CY2020Q1 | us-gaap |
Bank Owned Life Insurance
BankOwnedLifeInsurance
|
68174000 | USD |
CY2019Q4 | us-gaap |
Bank Owned Life Insurance
BankOwnedLifeInsurance
|
68883000 | USD |
CY2020Q1 | us-gaap |
Interest Receivable And Other Assets
InterestReceivableAndOtherAssets
|
50817000 | USD |
CY2019Q4 | us-gaap |
Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
|
832985000 | USD |
CY2020Q1 | us-gaap |
Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
|
2008757000 | USD |
CY2019Q4 | us-gaap |
Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
|
1965640000 | USD |
CY2020Q1 | us-gaap |
Time Deposits
TimeDeposits
|
599910000 | USD |
CY2019Q4 | us-gaap |
Time Deposits
TimeDeposits
|
631396000 | USD |
CY2020Q1 | us-gaap |
Deposits Domestic
DepositsDomestic
|
3478514000 | USD |
CY2019Q4 | us-gaap |
Deposits Domestic
DepositsDomestic
|
3430021000 | USD |
CY2020Q1 | us-gaap |
Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
|
207965000 | USD |
CY2019Q4 | us-gaap |
Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
|
349686000 | USD |
CY2020Q1 | us-gaap |
Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
|
53834000 | USD |
CY2019Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
|
44145000 | USD |
CY2020Q1 | us-gaap |
Liabilities
Liabilities
|
3740313000 | USD |
CY2019Q4 | us-gaap |
Liabilities
Liabilities
|
3823852000 | USD |
CY2020Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
26540000 | USD |
CY2019Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
26671000 | USD |
CY2019Q1 | gabc |
Interest Income Federal Funds Sold And Domestic Deposits
InterestIncomeFederalFundsSoldAndDomesticDeposits
|
141000 | USD |
CY2019Q1 | us-gaap |
Interest Expense Borrowings
InterestExpenseBorrowings
|
2182000 | USD |
CY2020Q1 | us-gaap |
Interest Expense
InterestExpense
|
7315000 | USD |
CY2019Q1 | us-gaap |
Interest Expense
InterestExpense
|
7598000 | USD |
CY2020Q1 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
274860000 | USD |
CY2019Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
278954000 | USD |
CY2020Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
253780000 | USD |
CY2019Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
253090000 | USD |
CY2020Q1 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
28360000 | USD |
CY2019Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
15105000 | USD |
CY2020Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
583540000 | USD |
CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
573820000 | USD |
CY2020Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
4323853000 | USD |
CY2019Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
4397672000 | USD |
CY2020Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
26540031 | shares |
CY2019Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
26671368 | shares |
CY2020Q1 | us-gaap |
Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
|
37858000 | USD |
CY2019Q1 | us-gaap |
Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
|
35119000 | USD |
CY2020Q1 | gabc |
Interest Income Federal Funds Sold And Domestic Deposits
InterestIncomeFederalFundsSoldAndDomesticDeposits
|
158000 | USD |
CY2020Q1 | gabc |
Interest Income Securities Taxable And Dividend Income Operating
InterestIncomeSecuritiesTaxableAndDividendIncomeOperating
|
3110000 | USD |
CY2019Q1 | gabc |
Interest Income Securities Taxable And Dividend Income Operating
InterestIncomeSecuritiesTaxableAndDividendIncomeOperating
|
3599000 | USD |
CY2020Q1 | us-gaap |
Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
|
2445000 | USD |
CY2019Q1 | us-gaap |
Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
|
2330000 | USD |
CY2020Q1 | us-gaap |
Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
|
43571000 | USD |
CY2019Q1 | us-gaap |
Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
|
41189000 | USD |
CY2020Q1 | us-gaap |
Interest Expense Domestic Deposits
InterestExpenseDomesticDeposits
|
5657000 | USD |
CY2019Q1 | us-gaap |
Interest Expense Domestic Deposits
InterestExpenseDomesticDeposits
|
5416000 | USD |
CY2020Q1 | us-gaap |
Interest Expense Borrowings
InterestExpenseBorrowings
|
1658000 | USD |
CY2020Q1 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
36256000 | USD |
CY2019Q1 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
33591000 | USD |
CY2020Q1 | us-gaap |
Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
|
5150000 | USD |
CY2019Q1 | us-gaap |
Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
|
675000 | USD |
CY2020Q1 | us-gaap |
Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
|
31106000 | USD |
CY2019Q1 | us-gaap |
Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
|
32916000 | USD |
CY2020Q1 | us-gaap |
Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
|
1222000 | USD |
CY2019Q1 | us-gaap |
Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
|
884000 | USD |
CY2020Q1 | us-gaap |
Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
|
427000 | USD |
CY2019Q1 | us-gaap |
Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
|
871000 | USD |
CY2020Q1 | us-gaap |
Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
|
1863000 | USD |
CY2019Q1 | us-gaap |
Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
|
981000 | USD |
CY2020Q1 | us-gaap |
Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
|
590000 | USD |
CY2019Q1 | us-gaap |
Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
|
155000 | USD |
CY2020Q1 | us-gaap |
Noninterest Income
NoninterestIncome
|
14081000 | USD |
CY2020Q1 | us-gaap |
Marketing And Advertising Expense
MarketingAndAdvertisingExpense
|
1071000 | USD |
CY2019Q1 | us-gaap |
Marketing And Advertising Expense
MarketingAndAdvertisingExpense
|
870000 | USD |
CY2019Q1 | us-gaap |
Noninterest Income
NoninterestIncome
|
11658000 | USD |
CY2020Q1 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
17400000 | USD |
CY2019Q1 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
15044000 | USD |
CY2020Q1 | us-gaap |
Occupancy Net
OccupancyNet
|
2570000 | USD |
CY2019Q1 | us-gaap |
Occupancy Net
OccupancyNet
|
2291000 | USD |
CY2020Q1 | us-gaap |
Equipment Expense
EquipmentExpense
|
1011000 | USD |
CY2019Q1 | us-gaap |
Equipment Expense
EquipmentExpense
|
928000 | USD |
CY2020Q1 | us-gaap |
Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
|
0 | USD |
CY2019Q1 | us-gaap |
Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
|
288000 | USD |
CY2020Q1 | us-gaap |
Information Technology And Data Processing
InformationTechnologyAndDataProcessing
|
1686000 | USD |
CY2019Q1 | us-gaap |
Information Technology And Data Processing
InformationTechnologyAndDataProcessing
|
1583000 | USD |
CY2020Q1 | us-gaap |
Professional Fees
ProfessionalFees
|
1084000 | USD |
CY2019Q1 | us-gaap |
Professional Fees
ProfessionalFees
|
1327000 | USD |
CY2020Q1 | us-gaap |
Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
|
960000 | USD |
CY2019Q1 | us-gaap |
Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
|
843000 | USD |
CY2020Q1 | us-gaap |
Other Noninterest Expense
OtherNoninterestExpense
|
4546000 | USD |
CY2019Q1 | us-gaap |
Other Noninterest Expense
OtherNoninterestExpense
|
3585000 | USD |
CY2020Q1 | us-gaap |
Noninterest Expense
NoninterestExpense
|
30328000 | USD |
CY2019Q1 | us-gaap |
Noninterest Expense
NoninterestExpense
|
26759000 | USD |
CY2020Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
14859000 | USD |
CY2019Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
17815000 | USD |
CY2020Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
2387000 | USD |
CY2019Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
2748000 | USD |
CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
12472000 | USD |
CY2019Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
15067000 | USD |
CY2020Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.47 | |
CY2019Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.60 | |
CY2020Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.47 | |
CY2019Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.60 | |
CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
12472000 | USD |
CY2019Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
15067000 | USD |
CY2020Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
17479000 | USD |
CY2019Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
12201000 | USD |
CY2020Q1 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
|
590000 | USD |
CY2019Q1 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
|
155000 | USD |
CY2020Q1 | us-gaap |
Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
|
3634000 | USD |
CY2019Q1 | us-gaap |
Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
|
2632000 | USD |
CY2020Q1 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
13255000 | USD |
CY2019Q1 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
9414000 | USD |
CY2020Q1 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
8271000 | USD |
CY2020Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-1121000 | USD |
CY2020Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
13255000 | USD |
CY2019Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
9414000 | USD |
CY2020Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
25727000 | USD |
CY2019Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
24481000 | USD |
CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
573820000 | USD |
CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
12472000 | USD |
CY2020Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
13255000 | USD |
CY2020Q1 | us-gaap |
Dividends Common Stock Cash
DividendsCommonStockCash
|
5065000 | USD |
CY2020Q1 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
270000 | USD |
CY2020Q1 | us-gaap |
Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
|
4495000 | USD |
CY2020Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
583540000 | USD |
CY2018Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
458640000 | USD |
CY2019Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
15067000 | USD |
CY2019Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
9414000 | USD |
CY2019Q1 | us-gaap |
Dividends Common Stock Cash
DividendsCommonStockCash
|
4245000 | USD |
CY2019Q1 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
311000 | USD |
CY2019Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
479187000 | USD |
CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
12472000 | USD |
CY2019Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
15067000 | USD |
CY2019Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-868000 | USD |
CY2020Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
2341000 | USD |
CY2019Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
2010000 | USD |
CY2020Q1 | us-gaap |
Payments For Origination And Purchases Of Loans Held For Sale
PaymentsForOriginationAndPurchasesOfLoansHeldForSale
|
54906000 | USD |
CY2019Q1 | us-gaap |
Payments For Origination And Purchases Of Loans Held For Sale
PaymentsForOriginationAndPurchasesOfLoansHeldForSale
|
33043000 | USD |
CY2020Q1 | us-gaap |
Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
|
58459000 | USD |
CY2019Q1 | us-gaap |
Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
|
29622000 | USD |
CY2020Q1 | us-gaap |
Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
|
5150000 | USD |
CY2019Q1 | us-gaap |
Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
|
675000 | USD |
CY2020Q1 | us-gaap |
Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
|
1863000 | USD |
CY2019Q1 | us-gaap |
Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
|
981000 | USD |
CY2020Q1 | us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
590000 | USD |
CY2019Q1 | us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
155000 | USD |
CY2020Q1 | gabc |
Gain Loss On Disposition Of Building And Equipment
GainLossOnDispositionOfBuildingAndEquipment
|
-27000 | USD |
CY2019Q1 | gabc |
Gain Loss On Disposition Of Building And Equipment
GainLossOnDispositionOfBuildingAndEquipment
|
0 | USD |
CY2020Q1 | gabc |
Gain Loss On Disposition Of Land
GainLossOnDispositionOfLand
|
0 | USD |
CY2019Q1 | gabc |
Gain Loss On Disposition Of Land
GainLossOnDispositionOfLand
|
262000 | USD |
CY2020Q1 | us-gaap |
Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
|
373000 | USD |
CY2019Q1 | us-gaap |
Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
|
331000 | USD |
CY2020Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
270000 | USD |
CY2019Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
311000 | USD |
CY2020Q1 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
6438000 | USD |
CY2019Q1 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-683000 | USD |
CY2019Q1 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
879000 | USD |
CY2020Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
23941000 | USD |
CY2019Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
15343000 | USD |
CY2020Q1 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
31698000 | USD |
CY2019Q1 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
18123000 | USD |
CY2020Q1 | us-gaap |
Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
|
10989000 | USD |
CY2019Q1 | us-gaap |
Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
|
11815000 | USD |
CY2020Q1 | us-gaap |
Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
47292000 | USD |
CY2019Q1 | us-gaap |
Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
30591000 | USD |
CY2020Q1 | us-gaap |
Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
|
0 | USD |
CY2019Q1 | us-gaap |
Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
|
521000 | USD |
CY2020Q1 | us-gaap |
Payments For Proceeds From Other Loans And Leases
PaymentsForProceedsFromOtherLoansAndLeases
|
-69603000 | USD |
CY2019Q1 | us-gaap |
Payments For Proceeds From Other Loans And Leases
PaymentsForProceedsFromOtherLoansAndLeases
|
-18808000 | USD |
CY2020Q1 | us-gaap |
Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
|
0 | USD |
CY2019Q1 | us-gaap |
Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
|
286000 | USD |
CY2020Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1166000 | USD |
CY2019Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1629000 | USD |
CY2020Q1 | us-gaap |
Proceeds From Sale Of Land Held For Use
ProceedsFromSaleOfLandHeldForUse
|
85000 | USD |
CY2019Q1 | us-gaap |
Proceeds From Sale Of Land Held For Use
ProceedsFromSaleOfLandHeldForUse
|
722000 | USD |
CY2020Q1 | us-gaap |
Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
|
1082000 | USD |
CY2019Q1 | us-gaap |
Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
|
1019000 | USD |
CY2020Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
64999000 | USD |
CY2019Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
18032000 | USD |
CY2020Q1 | us-gaap |
Increase Decrease In Deposits
IncreaseDecreaseInDeposits
|
48658000 | USD |
CY2019Q1 | us-gaap |
Increase Decrease In Deposits
IncreaseDecreaseInDeposits
|
-7184000 | USD |
CY2020Q1 | us-gaap |
Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
|
-134214000 | USD |
CY2019Q1 | us-gaap |
Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
|
-83904000 | USD |
CY2020Q1 | us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
0 | USD |
CY2019Q1 | us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
25000000 | USD |
CY2020Q1 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
7568000 | USD |
CY2019Q1 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
64000 | USD |
CY2020Q1 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
4495000 | USD |
CY2019Q1 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
0 | USD |
CY2020Q1 | us-gaap |
Payments Of Dividends
PaymentsOfDividends
|
5065000 | USD |
CY2019Q1 | us-gaap |
Payments Of Dividends
PaymentsOfDividends
|
4245000 | USD |
CY2020Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-102684000 | USD |
CY2019Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-70397000 | USD |
CY2020Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-13744000 | USD |
CY2019Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-37022000 | USD |
CY2019Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
103884000 | USD |
CY2018Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
96550000 | USD |
CY2020Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
90140000 | USD |
CY2019Q1 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
9034000 | USD |
CY2019Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
59528000 | USD |
CY2020Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
7701000 | USD |
CY2019Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
7468000 | USD |
CY2020Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
-45000 | USD |
CY2019Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
0 | USD |
CY2020Q1 | us-gaap |
Transfer To Other Real Estate
TransferToOtherRealEstate
|
200000 | USD |
CY2019Q1 | us-gaap |
Transfer To Other Real Estate
TransferToOtherRealEstate
|
685000 | USD |
CY2020Q1 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
0 | USD |
CY2020Q1 | us-gaap |
Basis Of Accounting
BasisOfAccounting
|
Basis of Presentation and Market Conditions<div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">German American Bancorp, Inc. operates primarily in the banking industry. The accounting and reporting policies of German American Bancorp, Inc. and its subsidiaries (hereinafter collectively referred to as the "Company") conform to U.S. generally accepted accounting principles. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted. All adjustments which are, in the opinion of management, necessary for a fair presentation of the results for the periods reported have been included in the accompanying unaudited consolidated financial statements, and all such adjustments are of a normal recurring nature. It is suggested that these consolidated financial statements and notes be read in conjunction with the financial statements and notes thereto in the Company's Annual Report on Form 10-K for the year ended December 31, 2019. Certain items included in the prior period financial statements were reclassified to conform to the current presentation. There was no effect on net income or total shareholders' equity based on these reclassifications.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Impact of COVID-19</span></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On January 30, 2020, the World Health Organization (“WHO”) announced that the outbreak of the novel coronavirus disease 2019 (COVID-19) constituted a public health emergency of international concern. On March 11, 2020, WHO declared COVID-19 to be a global pandemic and, on March 13, 2020, the President of the United States declared the COVID-19 outbreak a national emergency. The health concerns relating to the COVID-19 outbreak and related governmental actions taken to reduce the spread of the virus have significantly impacted the global economy (including the states and local economies in which we operate), disrupted supply chains, lowered equity market valuations, and created significant volatility and disruption in financial markets. The outbreak has resulted in authorities implementing numerous measures to try to contain the virus, such as travel bans and restrictions, quarantines, shelter in place or total lock-down orders and business limitations and shutdowns. Such measures have significantly contributed to rising unemployment and negatively impacted consumer and business spending. As a result, the demand for the Company’s products and services has been, and will continue to be, significantly impacted.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Furthermore, the outbreak could negatively impact our employees and customers’ ability to engage in banking and other financial transactions. The Company also could be adversely affected if key personnel or a significant number of employees were to become unavailable due to the effects and restrictions of a COVID-19 outbreak in our market areas. The fair value of certain assets could be impacted by the effects of COVID-19. The carrying value of goodwill, right-of-use lease assets, and other real estate owned could decrease resulting in future impairment losses. Management will continue to evaluate current economic conditions to determine if a triggering event would impact the current valuations for these assets. As a result, it is not currently possible to ascertain the overall impact of COVID-19 on the Company’s business. However, if the pandemic continues to evolve into a prolonged worldwide health crisis, the disease could have a material adverse effect on the Company’s business, results of operations, financial condition and cash flows.</span></div> | |
CY2020Q1 | gabc |
Number Of Loan Segments
NumberOfLoanSegments
|
8 | segment |
CY2019Q4 | gabc |
Number Of Loan Segments
NumberOfLoanSegments
|
6 | segment |
CY2019Q4 | us-gaap |
Financing Receivable Before Allowance For Credit Loss And Fee
FinancingReceivableBeforeAllowanceForCreditLossAndFee
|
3081973000 | USD |
CY2020Q1 | us-gaap |
Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
|
31931000 | USD |
CY2020Q1 | us-gaap |
Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
|
173000 | USD |
CY2020Q1 | gabc |
Financing Receivable Accrued Interest
FinancingReceivableAccruedInterest
|
12350000 | USD |
CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
12472000 | USD |
CY2019Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
15067000 | USD |
CY2020Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
26663145 | shares |
CY2019Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
24971863 | shares |
CY2020Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.47 | |
CY2019Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.60 | |
CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
12472000 | USD |
CY2019Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
15067000 | USD |
CY2020Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
26663145 | shares |
CY2019Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
24971863 | shares |
CY2020Q1 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
0 | shares |
CY2019Q1 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
0 | shares |
CY2020Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
26663145 | shares |
CY2019Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
24971863 | shares |
CY2020Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.47 | |
CY2019Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.60 | |
CY2020Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
0 | shares |
CY2020Q1 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
838923000 | USD |
CY2020Q1 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
36889000 | USD |
CY2020Q1 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
25000 | USD |
CY2020Q1 | us-gaap |
Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
|
0 | USD |
CY2020Q1 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
875787000 | USD |
CY2019Q4 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
834850000 | USD |
CY2019Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
21780000 | USD |
CY2019Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
1805000 | USD |
CY2019Q4 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
854825000 | USD |
CY2020Q1 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
|
3374000 | USD |
CY2020Q1 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
|
3378000 | USD |
CY2020Q1 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
|
19203000 | USD |
CY2020Q1 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
|
19593000 | USD |
CY2020Q1 | us-gaap |
Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
|
64814000 | USD |
CY2020Q1 | us-gaap |
Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
|
68114000 | USD |
CY2020Q1 | us-gaap |
Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
|
221668000 | USD |
CY2020Q1 | us-gaap |
Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
|
235779000 | USD |
CY2020Q1 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
838923000 | USD |
CY2020Q1 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
875787000 | USD |
CY2020Q1 | us-gaap |
Carrying Value Of Securities Sold Under Repurchase Agreements And Deposits Received For Securities Loaned
CarryingValueOfSecuritiesSoldUnderRepurchaseAgreementsAndDepositsReceivedForSecuritiesLoaned
|
249761000 | USD |
CY2019Q4 | us-gaap |
Carrying Value Of Securities Sold Under Repurchase Agreements And Deposits Received For Securities Loaned
CarryingValueOfSecuritiesSoldUnderRepurchaseAgreementsAndDepositsReceivedForSecuritiesLoaned
|
245664000 | USD |
CY2020Q1 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
|
2697000 | USD |
CY2020Q1 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
|
25000 | USD |
CY2020Q1 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
|
0 | USD |
CY2020Q1 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
|
0 | USD |
CY2020Q1 | us-gaap |
Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
|
2697000 | USD |
CY2020Q1 | us-gaap |
Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
|
25000 | USD |
CY2019Q4 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
|
93898000 | USD |
CY2019Q4 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
|
250000 | USD |
CY2019Q4 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
|
155989000 | USD |
CY2019Q4 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
|
1555000 | USD |
CY2019Q4 | us-gaap |
Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
|
249887000 | USD |
CY2019Q4 | us-gaap |
Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
|
1805000 | USD |
CY2020Q1 | us-gaap |
Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
|
0 | USD |
CY2020Q1 | gabc |
Debt Securities Availableforsale Interest Receivable
DebtSecuritiesAvailableforsaleInterestReceivable
|
4434000 | USD |
CY2009Q4 | us-gaap |
Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
|
1350000 | USD |
CY2009Q4 | us-gaap |
Equity Securities Without Readily Determinable Fair Value Impairment Loss Cumulative Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount
|
997000 | USD |
CY2020Q1 | us-gaap |
Equity Securities Without Readily Determinable Fair Value Impairment Loss Cumulative Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount
|
0 | USD |
CY2020Q1 | us-gaap |
Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
|
31485000 | USD |
CY2020Q1 | us-gaap |
Financing Receivable Before Allowance For Credit Loss And Fee
FinancingReceivableBeforeAllowanceForCreditLossAndFee
|
3018416000 | USD |
CY2019Q4 | us-gaap |
Financing Receivable Before Allowance For Credit Loss And Fee
FinancingReceivableBeforeAllowanceForCreditLossAndFee
|
3081973000 | USD |
CY2020Q1 | us-gaap |
Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount
FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount
|
-4683000 | USD |
CY2019Q4 | us-gaap |
Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount
FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount
|
-4882000 | USD |
CY2020Q1 | us-gaap |
Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
|
36641000 | USD |
CY2019Q4 | us-gaap |
Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
|
16278000 | USD |
CY2020Q1 | us-gaap |
Notes Receivable Net
NotesReceivableNet
|
2977092000 | USD |
CY2019Q4 | us-gaap |
Notes Receivable Net
NotesReceivableNet
|
3060813000 | USD |
CY2019Q4 | us-gaap |
Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
|
16278000 | USD |
CY2020Q1 | us-gaap |
Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
|
5150000 | USD |
CY2020Q1 | us-gaap |
Financing Receivable Allowance For Credit Loss Purchased With Credit Deterioration Increase
FinancingReceivableAllowanceForCreditLossPurchasedWithCreditDeteriorationIncrease
|
0 | USD |
CY2020Q1 | us-gaap |
Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
|
569000 | USD |
CY2020Q1 | us-gaap |
Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
|
129000 | USD |
CY2020Q1 | us-gaap |
Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
|
36641000 | USD |
CY2020Q1 | us-gaap |
Financing Receivable Nonaccrual No Allowance
FinancingReceivableNonaccrualNoAllowance
|
5526000 | USD |
CY2020Q1 | us-gaap |
Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
|
18099000 | USD |
CY2020Q1 | us-gaap |
Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
|
355000 | USD |
CY2020Q1 | us-gaap |
Financing Receivable Nonaccrual Interest Income
FinancingReceivableNonaccrualInterestIncome
|
3000 | USD |
CY2020Q1 | us-gaap |
Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
|
2986931000 | USD |
CY2020Q1 | us-gaap |
Financing Receivable Before Allowance For Credit Loss And Fee
FinancingReceivableBeforeAllowanceForCreditLossAndFee
|
3018416000 | USD |
CY2020Q1 | us-gaap |
Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
|
116000 | USD |
CY2020Q1 | gabc |
Troubleddebtrestructuringadditionallendingamount
Troubleddebtrestructuringadditionallendingamount
|
0 | USD |
CY2020Q1 | us-gaap |
Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
|
0 | loan |
CY2020Q1 | us-gaap |
Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
|
0 | loan |
CY2020Q1 | gabc |
Financing Receivable Individually Evaluatedfor Impairment Threshold Amount
FinancingReceivableIndividuallyEvaluatedforImpairmentThresholdAmount
|
250000 | USD |
CY2020Q1 | us-gaap |
Financing Receivable Significant Purchases
FinancingReceivableSignificantPurchases
|
0 | USD |
CY2020Q1 | us-gaap |
Financing Receivable Significant Sales
FinancingReceivableSignificantSales
|
252000 | USD |
CY2018Q4 | us-gaap |
Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
|
15823000 | USD |
CY2019Q1 | us-gaap |
Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
|
675000 | USD |
CY2019Q1 | us-gaap |
Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
|
146000 | USD |
CY2019Q1 | us-gaap |
Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
|
401000 | USD |
CY2019Q1 | us-gaap |
Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
|
16243000 | USD |
CY2019Q4 | us-gaap |
Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
|
2971000 | USD |
CY2019Q4 | us-gaap |
Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
|
11670000 | USD |
CY2019Q4 | us-gaap |
Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
|
12902000 | USD |
CY2019Q4 | us-gaap |
Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
|
16278000 | USD |
CY2019Q4 | us-gaap |
Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
|
6269000 | USD |
CY2019Q4 | us-gaap |
Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
|
3076835000 | USD |
CY2019Q4 | gabc |
Financing Receivable And Accrued Interest Before Allowance For Credit Loss And Fee
FinancingReceivableAndAccruedInterestBeforeAllowanceForCreditLossAndFee
|
3095902000 | USD |
CY2019Q4 | gabc |
Financing Receivable Accrued Interest
FinancingReceivableAccruedInterest
|
13929000 | USD |
CY2019Q4 | us-gaap |
Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
|
5320000 | USD |
CY2019Q4 | us-gaap |
Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
|
7229000 | USD |
CY2019Q4 | us-gaap |
Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
|
6386000 | USD |
CY2019Q4 | us-gaap |
Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
|
3371000 | USD |
CY2019Q4 | us-gaap |
Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
|
18899000 | USD |
CY2019Q4 | us-gaap |
Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
|
11706000 | USD |
CY2019Q4 | us-gaap |
Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
|
3371000 | USD |
CY2019Q1 | us-gaap |
Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
|
5444000 | USD |
CY2019Q1 | us-gaap |
Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
|
21000 | USD |
CY2019Q1 | us-gaap |
Impaired Financing Receivable With No Related Allowance Interest Income Cash Basis Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeCashBasisMethod
|
11000 | USD |
CY2019Q1 | us-gaap |
Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
|
6977000 | USD |
CY2019Q1 | us-gaap |
Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
|
0 | USD |
CY2019Q1 | us-gaap |
Impaired Financing Receivable With Related Allowance Interest Income Cash Basis Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeCashBasisMethod
|
0 | USD |
CY2019Q1 | us-gaap |
Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
|
12421000 | USD |
CY2019Q1 | us-gaap |
Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
|
21000 | USD |
CY2019Q1 | us-gaap |
Impaired Financing Receivable Interest Income Cash Basis Method
ImpairedFinancingReceivableInterestIncomeCashBasisMethod
|
11000 | USD |
CY2019Q4 | us-gaap |
Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
|
13802000 | USD |
CY2019Q4 | us-gaap |
Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
|
190000 | USD |
CY2019Q4 | gabc |
Financing Receivable And Accrued Interest Before Allowance For Credit Loss And Fee
FinancingReceivableAndAccruedInterestBeforeAllowanceForCreditLossAndFee
|
3095902000 | USD |
CY2019Q4 | us-gaap |
Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
|
19974000 | USD |
CY2019Q4 | us-gaap |
Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
|
3075928000 | USD |
CY2019Q4 | gabc |
Financing Receivable Accrued Interest
FinancingReceivableAccruedInterest
|
13929000 | USD |
CY2019 | us-gaap |
Financing Receivable Significant Purchases
FinancingReceivableSignificantPurchases
|
2051000 | USD |
CY2019 | us-gaap |
Financing Receivable Significant Sales
FinancingReceivableSignificantSales
|
0 | USD |
CY2020Q1 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
3 | segment |
CY2020Q1 | gabc |
Number Of Offices
NumberOfOffices
|
75 | office |
CY2020Q1 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
3 | segment |
CY2020Q1 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
36256000 | USD |
CY2020Q1 | us-gaap |
Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
|
1863000 | USD |
CY2020Q1 | us-gaap |
Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
|
590000 | USD |
CY2020Q1 | gabc |
Fees And Commissions Fiduciary And Trust Activities And Brokerage Commissions Revenue
FeesAndCommissionsFiduciaryAndTrustActivitiesAndBrokerageCommissionsRevenue
|
2031000 | USD |
CY2020Q1 | us-gaap |
Insurance Commissions And Fees
InsuranceCommissionsAndFees
|
3229000 | USD |
CY2020Q1 | us-gaap |
Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
|
5150000 | USD |
CY2020Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
2341000 | USD |
CY2020Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
2387000 | USD |
CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
12472000 | USD |
CY2020Q1 | us-gaap |
Assets
Assets
|
4323853000 | USD |
CY2019Q1 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
33591000 | USD |
CY2019Q1 | us-gaap |
Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
|
981000 | USD |
CY2019Q1 | us-gaap |
Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
|
155000 | USD |
CY2019Q1 | gabc |
Fees And Commissions Fiduciary And Trust Activities And Brokerage Commissions Revenue
FeesAndCommissionsFiduciaryAndTrustActivitiesAndBrokerageCommissionsRevenue
|
1567000 | USD |
CY2019Q1 | us-gaap |
Insurance Commissions And Fees
InsuranceCommissionsAndFees
|
3205000 | USD |
CY2019Q1 | us-gaap |
Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
|
675000 | USD |
CY2019Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
2010000 | USD |
CY2019Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
2748000 | USD |
CY2019Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
15067000 | USD |
CY2019Q4 | us-gaap |
Assets
Assets
|
4397672000 | USD |
CY2020Q1 | us-gaap |
Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
|
15561000 | USD |
CY2019Q4 | us-gaap |
Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
|
17713000 | USD |
CY2020Q1 | us-gaap |
Loans Receivable Held For Sale Amount
LoansReceivableHeldForSaleAmount
|
15221000 | USD |
CY2020Q1 | us-gaap |
Fair Value Option Loans Held As Assets Aggregate Difference
FairValueOptionLoansHeldAsAssetsAggregateDifference
|
340000 | USD |
CY2019Q4 | us-gaap |
Fair Value Option Loans Held As Assets Aggregate Difference
FairValueOptionLoansHeldAsAssetsAggregateDifference
|
335000 | USD |
CY2020Q1 | gabc |
Sharebased Compensation Arrangementby Sharebased Payment Award Numberof Plans
SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPlans
|
2 | Plan |
CY2020Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
0 | shares |
CY2020Q1 | us-gaap |
Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
|
41752 | shares |
CY2019Q1 | us-gaap |
Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
|
24780 | shares |
CY2020Q1 | us-gaap |
Restricted Stock Expense
RestrictedStockExpense
|
270000 | USD |
CY2019Q1 | us-gaap |
Restricted Stock Expense
RestrictedStockExpense
|
311000 | USD |
CY2020Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
244000 | USD |
CY2019Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
150000 | USD |
CY2020Q1 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
128000 | USD |
CY2019Q1 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
120000 | USD |
CY2020Q1 | us-gaap |
Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
|
386000 | USD |
CY2019Q1 | us-gaap |
Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
|
341000 | USD |
CY2019Q4 | us-gaap |
Loans Receivable Held For Sale Amount
LoansReceivableHeldForSaleAmount
|
17378000 | USD |
CY2020Q1 | us-gaap |
Other Real Estate And Foreclosed Assets
OtherRealEstateAndForeclosedAssets
|
0 | USD |
CY2020Q1 | gabc |
Real Estate Owned Carrying Value Less Coststo Sell Write Down
RealEstateOwnedCarryingValueLessCoststoSellWriteDown
|
0 | USD |
CY2019Q4 | us-gaap |
Other Real Estate And Foreclosed Assets
OtherRealEstateAndForeclosedAssets
|
0 | USD |
CY2019 | gabc |
Real Estate Owned Carrying Value Less Coststo Sell Write Down
RealEstateOwnedCarryingValueLessCoststoSellWriteDown
|
0 | USD |
CY2020Q1 | us-gaap |
Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
|
13718000 | USD |
CY2020Q1 | us-gaap |
Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
|
463000 | USD |
CY2020Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
13255000 | USD |
CY2019Q1 | us-gaap |
Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
|
9536000 | USD |
CY2019Q1 | us-gaap |
Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
|
122000 | USD |
CY2019Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
9414000 | USD |
CY2020Q1 | us-gaap |
Noninterest Income
NoninterestIncome
|
14081000 | USD |
CY2019Q1 | us-gaap |
Noninterest Income
NoninterestIncome
|
11658000 | USD |
CY2020Q1 | us-gaap |
Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
|
52000 | USD |
CY2019Q1 | us-gaap |
Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
|
52000 | USD |
CY2020Q1 | us-gaap |
Finance Lease Interest Expense
FinanceLeaseInterestExpense
|
92000 | USD |
CY2019Q1 | us-gaap |
Finance Lease Interest Expense
FinanceLeaseInterestExpense
|
96000 | USD |
CY2020Q1 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
453000 | USD |
CY2019Q1 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
360000 | USD |
CY2020Q1 | us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
25000 | USD |
CY2019Q1 | us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
15000 | USD |
CY2020Q1 | us-gaap |
Lease Cost
LeaseCost
|
622000 | USD |
CY2019Q1 | us-gaap |
Lease Cost
LeaseCost
|
523000 | USD |
CY2020Q1 | us-gaap |
Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
|
P12Y | |
CY2019Q1 | us-gaap |
Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
|
P13Y | |
CY2020Q1 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P8Y | |
CY2019Q1 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P9Y | |
CY2020Q1 | us-gaap |
Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
|
0.1148 | |
CY2019Q1 | us-gaap |
Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
|
0.1150 | |
CY2020Q1 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0318 | |
CY2019Q1 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0344 | |
CY2020Q1 | gabc |
Finance Lease Right Of Use Asset Gross
FinanceLeaseRightOfUseAssetGross
|
2435000 | USD |
CY2019Q1 | gabc |
Finance Lease Right Of Use Asset Gross
FinanceLeaseRightOfUseAssetGross
|
2645000 | USD |
CY2020Q1 | us-gaap |
Finance Lease Liability
FinanceLeaseLiability
|
3343000 | USD |
CY2019Q1 | us-gaap |
Finance Lease Liability
FinanceLeaseLiability
|
3488000 | USD |
CY2020Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
9215000 | USD |
CY2019Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
8750000 | USD |
CY2020Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
9289000 | USD |
CY2019Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
8767000 | USD |
CY2020Q1 | us-gaap |
Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
|
92000 | USD |
CY2019Q1 | us-gaap |
Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
|
96000 | USD |
CY2020Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
412000 | USD |
CY2019Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
343000 | USD |
CY2020Q1 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
30000 | USD |
CY2019Q1 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
26000 | USD |
CY2020Q1 | us-gaap |
Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
|
519000 | USD |
CY2020Q1 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
1658000 | USD |
CY2020Q1 | us-gaap |
Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
|
519000 | USD |
CY2020Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
1445000 | USD |
CY2020Q1 | us-gaap |
Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
|
519000 | USD |
CY2020Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
1319000 | USD |
CY2020Q1 | us-gaap |
Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
|
519000 | USD |
CY2020Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
1158000 | USD |
CY2020Q1 | us-gaap |
Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
|
519000 | USD |
CY2020Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
|
1050000 | USD |
CY2020Q1 | us-gaap |
Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
|
3343000 | USD |
CY2020Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
|
4089000 | USD |
CY2020Q1 | us-gaap |
Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
|
5938000 | USD |
CY2020Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
10719000 | USD |
CY2020Q1 | us-gaap |
Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
|
2595000 | USD |
CY2020Q1 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
1430000 | USD |
CY2020Q1 | us-gaap |
Finance Lease Liability
FinanceLeaseLiability
|
3343000 | USD |
CY2020Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
9289000 | USD |